Pharma Sources Insight第十二期 | 新药出海的奏鸣

2024-06-27

抗体药物偶联物临床1期

关注并星标CPHI制药在线扫描二维码开始阅读 Scan to preview the contents. Pharma Sources Insight June 2024 focuses on the following topics: BRAND STORY - NENTER & Co., Inc. Products List FROM THE EDITOR - The Speed of New Drug Popularization, Blockbuster Drug Development, and Upstarts Becoming Upstarts GLOBAL PHARMA INDUSTRY - Uncovering the Core of Drug Shortages in the United States - Generic Equivalent to Branded Drug, What Are the Facts NEW DRUG R&D - How to Select Blister Packaging Machine for Your Application - Research Progress on Organoids and Microfluidics in Pharmaceutical Research and Development - Drug Delivery on the Go: Wearable Delivery Systems - Decoding the Role of Synthetic Biology in Pharmaceuticals PHARMA IN CHINA - Looking at Hengrui’s $6 Billion Out-Licensing Overseas: What Are the New Opportunities in the Weight-Loss Drug Sector? - Chinese Companies Leading the ADC R&D Pipeline - Popular Products and Companies at PharmaSources.com INDUSTRY INSIGHT - Globalization of Dugs : A Double-Edged Sword with Room for Improvement About Pharma Sources Insight Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world. Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPHI China. 往期回顾 Previous Review 点击阅读原文，免费阅读往期内容 Pharma Sources Insight第十一期 | 2024全球制药行业前瞻第十一期：https://flbook.com.cn/c/wk084AM9mv Pharma Sources Insight, Your FREE source of news and insights into China pharmaceutical industry, and more!

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

适应症

靶点

药物